Predictive factors for metastatic infection in patients with bacteremia caused by methicillin-sensitive staphylococcus aureus

American Journal of the Medical Sciences

Volumn 349, Issue 1, 2015, Pages 24-28

  Horino, Tetsuya ^a   Sato, Fumiya ^a   Hosaka, Yumiko ^a   Hoshina, Tokio ^a   Tamura, Kumi ^a   Nakaharai, Kazuhiko ^a   Kato, Tetsuro ^a   Nakazawa, Yasushi ^a   Yoshida, Masaki ^a   Hori, Seiji ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bacteremia; Metastatic infection; Predictive factors; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; ANTIINFECTIVE AGENT; METICILLIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; CATHETER INFECTION; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; EPIDURAL ABSCESS; FEMALE; FEVER; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INTERVERTEBRAL DISK DEGENERATION; LUNG ABSCESS; MAJOR CLINICAL STUDY; MALE; METASTATIC INFECTION; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; PREDICTION; PSOAS ABSCESS; RETROSPECTIVE STUDY; SPONDYLITIS; THERAPY DELAY; TREATMENT OUTCOME; BLOOD; CATHETER-RELATED INFECTIONS; JAPAN; MICROBIOLOGY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; C-REACTIVE PROTEIN; CATHETER-RELATED INFECTIONS; FEMALE; FEVER; HUMANS; JAPAN; MALE; METHICILLIN; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84927939466     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/maj.0000000000000350     Document Type: Article

References (22)

1. Shorr AF, Tabak YP, Killian AD, et al. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large U.S. database. Crit Care Med 2006;34:2588-95.
2. Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309-17.
3. Choi SH, Chung JW. Time to positivity of follow-up blood cultures in patients with persistent Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2012;31:2963-7.
4. Cuijpers ML, Vos FJ, Bleeker-Rovers CP, et al. Complicating infectious foci in patients with Staphylococcus aureus or Streptococcus species bacteraemia. Eur J Clin Microbiol Infect Dis 2007;26:105-13.
5. Fowler VG Jr, Justice A, Moore C, et al. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis 2005;40:695-703.
6. Fowler VG Jr, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998;27:478-86.
7. Jenkins TC, Price CS, Sabel AL, et al. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008;46: 1000-8.
8. Jensen AG, Wachmann CH, Espersen F, et al. Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases. Arch Intern Med 2002;162:25-32.
9. Lesens O, Hansmann Y, Brannigan E, et al. Positive surveillance blood culture is a predictive factor for secondary metastatic infection in patients with Staphylococcus aureus bacteraemia. J Infect 2004;48: 245-52.
10. Rieg S, Peyerl-Hoffmann G, de With K, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation-a study of 521 patients in Germany. J Infect 2009;59:232-9.
11. Fowler VG Jr, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 2003; 163:2066-72.
12. Vos FJ, Kullberg BJ, Sturm PD, et al. Metastatic infectious disease and clinical outcome in Staphylococcus aureus and Streptococcus species bacteremia. Medicine (Baltimore) 2012;91:86-94.
13. Paul M, Kariv G, Goldberg E, et al. Importance of appropriate empirical antibiotic therapy for methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother 2010;65:2658-65.
14. Bassetti M, Trecarichi EM, Mesini A, et al. Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2012;18:862-9.
15. Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the nfectious Diseases Society of America. Clin Infect Dis 2013;56: e1-25.
16. Tschaikowsky K, Hedwig-Geissing M, Schmidt J, et al. Lipopolysaccharide-binding protein for monitoring of postoperative sepsis: complemental to C-reactive protein or redundant? PLoS One 2011;6:e23615.
17. Komiya K, Ishii H, Teramoto S, et al. Plasma C-reactive protein levels are associated with mortality in elderly with acute lung injury. J Crit Care 2012;27:524.e1-6.
18. Lobo SM, Lobo FR, Bota DP, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003; 123:2043-9.
19. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:e18-55.
20. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1-45.
21. Welsch T, Frommhold K, Hinz U, et al. Persisting elevation of C-reactive protein after pancreatic resections can indicate developing inflammatory complications. Surgery 2008;143: 20-8.
22. Lee CC, Chen SY, Tsai CL, et al. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Shock 2008; 29:322-7.